KJ
Kurva Joshi Raghavendraprasad
About Kurva Joshi Raghavendraprasad
Data last updated:
Kurva Joshi Raghavendraprasad has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Rex Genia Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rex Genia Life Sciences Private Limited at ₹3.71 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Feb 2022 | 2016 | ₹3.71 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kurva Joshi Raghavendraprasad
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kurva Joshi Raghavendraprasad
Kurva Joshi Raghavendraprasad has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Rex Genia Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rex Genia Life Sciences Private Limited at ₹3.71 Cr (FY 2025).
Kurva Joshi Raghavendraprasad is associated with 1 company as Director, including Rex Genia Life Sciences Private Limited (₹3.71 Cr).
Kurva Joshi Raghavendraprasad has expertise in General Business.
Kurva Joshi Raghavendraprasad has 4 years in corporate governance.
By reported revenue, the largest current company of Kurva Joshi Raghavendraprasad is Rex Genia Life Sciences Private Limited, with revenue of ₹3.71 Cr (FY 2025).
Kurva Joshi Raghavendraprasad currently holds positions at 1 company: Rex Genia Life Sciences Private Limited (₹3.71 Cr).